ReviewAnnals of hematology2025

Optimizing the use of melflufen (melphalan flufenamide) in relapsed or refractory multiple myeloma: recommendations for clinical practice.

Heinz Ludwig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.